DK1951738T3 - Nye krystallinske former af rostafuroxin - Google Patents

Nye krystallinske former af rostafuroxin

Info

Publication number
DK1951738T3
DK1951738T3 DK06819722.7T DK06819722T DK1951738T3 DK 1951738 T3 DK1951738 T3 DK 1951738T3 DK 06819722 T DK06819722 T DK 06819722T DK 1951738 T3 DK1951738 T3 DK 1951738T3
Authority
DK
Denmark
Prior art keywords
crystalline forms
rostafuroxin
new crystalline
new
forms
Prior art date
Application number
DK06819722.7T
Other languages
English (en)
Inventor
Alberto Cerri
Silvia Armaroli
Marco Torri
Original Assignee
Rostaquo S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rostaquo S P A filed Critical Rostaquo S P A
Application granted granted Critical
Publication of DK1951738T3 publication Critical patent/DK1951738T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK06819722.7T 2005-11-25 2006-11-23 Nye krystallinske former af rostafuroxin DK1951738T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025817 2005-11-25
PCT/EP2006/068845 WO2007060206A2 (en) 2005-11-25 2006-11-23 Further crystalline forms of rostafuroxin

Publications (1)

Publication Number Publication Date
DK1951738T3 true DK1951738T3 (da) 2012-04-23

Family

ID=36165370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06819722.7T DK1951738T3 (da) 2005-11-25 2006-11-23 Nye krystallinske former af rostafuroxin

Country Status (10)

Country Link
US (1) US9127037B2 (da)
EP (1) EP1951738B1 (da)
AT (1) ATE541855T1 (da)
CY (1) CY1112973T1 (da)
DK (1) DK1951738T3 (da)
ES (1) ES2380491T3 (da)
PL (1) PL1951738T3 (da)
PT (1) PT1951738E (da)
SI (1) SI1951738T1 (da)
WO (1) WO2007060206A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
PT2490694E (pt) * 2009-10-19 2015-12-02 Rostaquo S P A Rostafuroxina para tratamento farmacogenómico de doenças cardiovasculares
EP2640847A1 (en) 2010-11-19 2013-09-25 Fondazione Centro San Raffaele del Monte Tabor Markers for acute kidney injury and uses thereof
CN102940640A (zh) * 2012-12-06 2013-02-27 中国生命药物治疗有限公司 罗他夫辛在制备治疗基因缺陷型原发性高血压的药物中的用途
CN108096207B (zh) * 2017-12-29 2021-01-01 兆科药业（合肥）有限公司 一种罗他夫辛肠溶片的制备方法
US11337988B2 (en) 2018-09-27 2022-05-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of ouabain antagonists to inhibit viral infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
IT1282286B1 (it) * 1995-05-11 1998-03-16 Sigma Tau Ind Farmaceuti Seco-d steroidi sul sistema cardiovascolare, processi per la loro preparazione e composizioni farmaceutiche che li contengono.

Also Published As

Publication number Publication date
PT1951738E (pt) 2012-04-18
PL1951738T3 (pl) 2012-06-29
EP1951738A2 (en) 2008-08-06
ES2380491T3 (es) 2012-05-14
EP1951738B1 (en) 2012-01-18
WO2007060206A2 (en) 2007-05-31
CY1112973T1 (el) 2016-04-13
US9127037B2 (en) 2015-09-08
WO2007060206A3 (en) 2007-08-30
ATE541855T1 (de) 2012-02-15
SI1951738T1 (sl) 2012-06-29
US20080300228A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ECSP078055A (es) Formas sólidas cristalinas de tigeciclina y métodos para preparar las mismas
BRPI0606132A2 (pt) formas cristalinas de docetaxel e processos para seu preparo
CY1116261T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
NO20092611L (no) Krystallinsk faststoff Rasagilin base
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
ECSP088831A (es) Anticuerpos anti-tat226 e inmunoconjugados
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
GT200600264A (es) Modificaciones cristalinas de piraclostrobina
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
EP2446904A3 (en) Anti-CD22 antibodies, their immunoconjugates and uses thereof
BRPI0809366A8 (pt) polipeptídeos interligados
BRPI0510170B8 (pt) composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
BRPI0810552A2 (pt) Composição de substância ativa, processos para preparar uma composição de substância ativa, e para preparar sementes contenda substância ativa, uso da composição de substância ativa, sementes, e, composição aquosa.
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
CY1112973T1 (el) Περαιτερω κρυσταλλικες μορφες ροσταφουροξινης
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
EA201070059A1 (ru) Композиции, содержащие ингибиторы триптофангидроксилазы
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
BRPI0905723A2 (pt) Uso de pelo menos uma semente de uma planta do gênero capsicum, composição e composição farmacêutica